Exact Mass: 519.2805
Exact Mass Matches: 519.2805
Found 500 metabolites which its exact mass value is equals to given mass value 519.2805
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Vignatic acid B
Vignatic acid B is found in pulses. Vignatic acid B is a constituent of Vigna radiata (mung bean). Constituent of Vigna radiata (mung bean). Vignatic acid B is found in pulses.
[(3R,4S)-1,1-Difluoro-3-(hexadecanoylamino)-4-hydroxy-4-phenylbutyl]phosphonic acid
[(3S,5S,7S)-7-{(1E,3E)-5-[(2S,3S,5R,6R)-5-{[(2Z,4S)-4-(acetyloxy)pent-2-enoyl]amino}-3,6-dimethyltetrahydro-2H-pyran-2-yl]-3-methylpenta-1,3-dien-1-yl}-1,6-dioxaspiro[2.5]oct-5-yl]acetic acid
[(2S,5S,6R)-6-{(1E,3E)-5-[(2S,3S,5R,6R)-5-{[(2Z,4S)-4-(acetyloxy)pent-2-enoyl]amino}-3,6-dimethyltetrahydro-2H-pyran-2-yl]-3-methylpenta-1,3-dien-1-yl}-5-hydroxy-4-methylidenetetrahydro-2H-pyran-2-yl]acetic acid
4,5-dihydro-7-O-descarbamoyl-7-hydroxygeldanamycin
Ala His His Arg
Ala His Arg His
Ala Arg His His
Cys Lys Asn Arg
Cys Lys Arg Asn
Cys Asn Lys Arg
Cys Asn Arg Lys
Cys Arg Lys Asn
Cys Arg Asn Lys
Glu Phe Lys Pro
Glu Phe Pro Lys
Glu Ile Lys Met
Glu Ile Met Lys
Glu Lys Phe Pro
Glu Lys Ile Met
Glu Lys Leu Met
Glu Lys Met Ile
Glu Lys Met Leu
Glu Lys Pro Phe
Glu Leu Lys Met
Glu Leu Met Lys
Glu Met Ile Lys
Glu Met Lys Ile
Glu Met Lys Leu
Glu Met Leu Lys
Glu Pro Phe Lys
Glu Pro Lys Phe
Phe Glu Lys Pro
Phe Glu Pro Lys
Phe Ile Ile Gln
Phe Ile Leu Gln
Phe Ile Gln Ile
Phe Ile Gln Leu
Phe Lys Glu Pro
Phe Lys Pro Glu
Phe Leu Ile Gln
Phe Leu Leu Gln
Phe Leu Gln Ile
Phe Leu Gln Leu
Phe Pro Glu Lys
Phe Pro Lys Glu
Phe Pro Arg Thr
Phe Pro Thr Arg
Phe Gln Ile Ile
Phe Gln Ile Leu
Phe Gln Leu Ile
Phe Gln Leu Leu
Phe Arg Pro Thr
Phe Arg Thr Pro
Phe Thr Pro Arg
Phe Thr Arg Pro
His Ala His Arg
His Ala Arg His
His His Ala Arg
His His Ile Asn
His His Lys Val
His His Leu Asn
His His Asn Ile
His His Asn Leu
His His Gln Val
His His Arg Ala
His His Val Lys
His His Val Gln
His Ile His Asn
His Ile Asn His
His Lys His Val
His Lys Val His
His Leu His Asn
His Leu Asn His
His Asn His Ile
His Asn His Leu
His Asn Ile His
His Asn Leu His
His Gln His Val
His Gln Val His
His Arg Ala His
His Arg His Ala
His Val His Lys
His Val His Gln
His Val Lys His
His Val Gln His
Ile Glu Lys Met
Ile Glu Met Lys
Ile Phe Ile Gln
Ile Phe Leu Gln
Ile Phe Gln Ile
Ile Phe Gln Leu
Ile His His Asn
Ile His Asn His
Ile Ile Phe Gln
Ile Ile Gln Phe
Ile Lys Glu Met
Ile Lys Met Glu
Ile Lys Pro Tyr
Ile Lys Tyr Pro
Ile Leu Phe Gln
Ile Leu Gln Phe
Ile Met Glu Lys
Ile Met Lys Glu
Ile Met Arg Thr
Ile Met Thr Arg
Ile Asn His His
Ile Pro Lys Tyr
Ile Pro Gln Tyr
Ile Pro Tyr Lys
Ile Pro Tyr Gln
Ile Gln Phe Ile
Ile Gln Phe Leu
Ile Gln Ile Phe
Ile Gln Leu Phe
Ile Gln Pro Tyr
Ile Gln Tyr Pro
Ile Arg Met Thr
Ile Arg Thr Met
Ile Thr Met Arg
Ile Thr Arg Met
Ile Thr Thr Trp
Ile Thr Trp Thr
Ile Trp Thr Thr
Ile Tyr Lys Pro
Ile Tyr Pro Lys
Ile Tyr Pro Gln
Ile Tyr Gln Pro
Lys Cys Asn Arg
Lys Cys Arg Asn
Lys Glu Phe Pro
Lys Glu Ile Met
Lys Glu Leu Met
Lys Glu Met Ile
Lys Glu Met Leu
Lys Glu Pro Phe
Lys Phe Glu Pro
Lys Phe Pro Glu
Lys His His Val
Lys His Val His
Lys Ile Glu Met
Lys Ile Met Glu
Lys Ile Pro Tyr
Lys Ile Tyr Pro
Lys Lys Met Asn
Lys Lys Asn Met
Lys Leu Glu Met
Lys Leu Met Glu
Lys Leu Pro Tyr
Lys Leu Tyr Pro
Lys Met Glu Ile
Lys Met Glu Leu
Lys Met Ile Glu
Lys Met Lys Asn
Lys Met Leu Glu
Lys Met Asn Lys
Lys Asn Cys Arg
Lys Asn Lys Met
Lys Asn Met Lys
Lys Asn Arg Cys
Lys Pro Glu Phe
Lys Pro Phe Glu
Lys Pro Ile Tyr
Lys Pro Leu Tyr
Lys Pro Tyr Ile
Lys Pro Tyr Leu
Lys Arg Cys Asn
Lys Arg Asn Cys
Lys Val His His
Lys Tyr Ile Pro
Lys Tyr Leu Pro
Lys Tyr Pro Ile
Lys Tyr Pro Leu
Leu Glu Lys Met
Leu Glu Met Lys
Leu Phe Ile Gln
Leu Phe Leu Gln
Leu Phe Gln Ile
Leu Phe Gln Leu
Leu His His Asn
Leu His Asn His
Leu Ile Phe Gln
Leu Ile Gln Phe
Leu Lys Glu Met
Leu Lys Met Glu
Leu Lys Pro Tyr
Leu Lys Tyr Pro
Leu Leu Phe Gln
Leu Leu Gln Phe
Leu Met Glu Lys
Leu Met Lys Glu
Leu Met Arg Thr
Leu Met Thr Arg
Leu Asn His His
Leu Pro Lys Tyr
Leu Pro Gln Tyr
Leu Pro Tyr Lys
Leu Pro Tyr Gln
Leu Gln Phe Ile
Leu Gln Phe Leu
Leu Gln Ile Phe
Leu Gln Leu Phe
Leu Gln Pro Tyr
Leu Gln Tyr Pro
Leu Arg Met Thr
Leu Arg Thr Met
Leu Thr Met Arg
Leu Thr Arg Met
Leu Thr Thr Trp
Leu Thr Trp Thr
Leu Trp Thr Thr
Leu Tyr Lys Pro
Leu Tyr Pro Lys
Leu Tyr Pro Gln
Leu Tyr Gln Pro
Met Glu Ile Lys
Met Glu Lys Ile
Met Glu Lys Leu
Met Glu Leu Lys
Met Ile Glu Lys
Met Ile Lys Glu
Met Ile Arg Thr
Met Ile Thr Arg
Met Lys Glu Ile
Met Lys Glu Leu
Met Lys Ile Glu
Met Lys Lys Asn
Met Lys Leu Glu
Met Lys Asn Lys
Met Leu Glu Lys
Met Leu Lys Glu
Met Leu Arg Thr
Met Leu Thr Arg
Met Asn Lys Lys
Met Arg Ile Thr
Met Arg Leu Thr
Met Arg Thr Ile
Met Arg Thr Leu
Met Thr Ile Arg
Met Thr Leu Arg
Met Thr Arg Ile
Met Thr Arg Leu
Asn Cys Lys Arg
Asn Cys Arg Lys
Asn His His Ile
Asn His His Leu
Asn His Ile His
Asn His Leu His
Asn Ile His His
Asn Lys Cys Arg
Asn Lys Lys Met
Asn Lys Met Lys
Asn Lys Arg Cys
Asn Leu His His
Asn Met Lys Lys
Asn Arg Cys Lys
Asn Arg Lys Cys
Pro Glu Phe Lys
Pro Glu Lys Phe
Pro Phe Glu Lys
Pro Phe Lys Glu
Pro Phe Arg Thr
Pro Phe Thr Arg
Pro Ile Lys Tyr
Pro Ile Gln Tyr
Pro Ile Tyr Lys
Pro Ile Tyr Gln
Pro Lys Glu Phe
Pro Lys Phe Glu
Pro Lys Ile Tyr
Pro Lys Leu Tyr
Pro Lys Tyr Ile
Pro Lys Tyr Leu
Pro Leu Lys Tyr
Pro Leu Gln Tyr
Pro Leu Tyr Lys
Pro Leu Tyr Gln
Pro Gln Ile Tyr
Pro Gln Leu Tyr
Pro Gln Tyr Ile
Pro Gln Tyr Leu
Pro Arg Phe Thr
Pro Arg Thr Phe
Pro Thr Phe Arg
Pro Thr Arg Phe
Pro Tyr Ile Lys
Pro Tyr Ile Gln
Pro Tyr Lys Ile
Pro Tyr Lys Leu
Pro Tyr Leu Lys
Pro Tyr Leu Gln
Pro Tyr Gln Ile
Pro Tyr Gln Leu
Gln Phe Ile Ile
Gln Phe Ile Leu
Gln Phe Leu Ile
Gln Phe Leu Leu
Gln His His Val
Gln His Val His
Gln Ile Phe Ile
Gln Ile Phe Leu
Gln Ile Ile Phe
Gln Ile Leu Phe
Gln Ile Pro Tyr
Gln Ile Tyr Pro
Gln Leu Phe Ile
Gln Leu Phe Leu
Gln Leu Ile Phe
Gln Leu Leu Phe
Gln Leu Pro Tyr
Gln Leu Tyr Pro
Gln Pro Ile Tyr
Gln Pro Leu Tyr
Gln Pro Tyr Ile
Gln Pro Tyr Leu
Gln Val His His
Gln Tyr Ile Pro
Gln Tyr Leu Pro
Gln Tyr Pro Ile
Gln Tyr Pro Leu
Arg Ala His His
Arg Cys Lys Asn
Arg Cys Asn Lys
Arg Phe Pro Thr
Arg Phe Thr Pro
Arg His Ala His
Arg His His Ala
Arg Ile Met Thr
Arg Ile Thr Met
Arg Lys Cys Asn
Arg Lys Asn Cys
Arg Leu Met Thr
Arg Leu Thr Met
Arg Met Ile Thr
Arg Met Leu Thr
Arg Met Thr Ile
Arg Met Thr Leu
Arg Asn Cys Lys
Arg Asn Lys Cys
Arg Pro Phe Thr
Arg Pro Thr Phe
Arg Thr Phe Pro
Arg Thr Ile Met
Arg Thr Leu Met
Arg Thr Met Ile
Arg Thr Met Leu
Arg Thr Pro Phe
Thr Phe Pro Arg
Thr Phe Arg Pro
Thr Ile Met Arg
Thr Ile Arg Met
Thr Ile Thr Trp
Thr Ile Trp Thr
Thr Leu Met Arg
Thr Leu Arg Met
Thr Leu Thr Trp
Thr Leu Trp Thr
Thr Met Ile Arg
Thr Met Leu Arg
Thr Met Arg Ile
Thr Met Arg Leu
Thr Pro Phe Arg
Thr Pro Arg Phe
Thr Arg Phe Pro
Thr Arg Ile Met
Thr Arg Leu Met
Thr Arg Met Ile
Thr Arg Met Leu
Thr Arg Pro Phe
Thr Thr Ile Trp
Thr Thr Leu Trp
Thr Thr Trp Ile
Thr Thr Trp Leu
Thr Trp Ile Thr
Thr Trp Leu Thr
Thr Trp Thr Ile
Thr Trp Thr Leu
Val His His Lys
Val His His Gln
Val His Lys His
Val His Gln His
Val Lys His His
Val Gln His His
Trp Ile Thr Thr
Trp Leu Thr Thr
Trp Thr Ile Thr
Trp Thr Leu Thr
Trp Thr Thr Ile
Trp Thr Thr Leu
Tyr Ile Lys Pro
Tyr Ile Pro Lys
Tyr Ile Pro Gln
Tyr Ile Gln Pro
Tyr Lys Ile Pro
Tyr Lys Leu Pro
Tyr Leu Pro Gln
Tyr Leu Gln Pro
Tyr Pro Ile Gln
Tyr Pro Leu Gln
Tyr Pro Gln Ile
Tyr Pro Gln Leu
Tyr Gln Ile Pro
Tyr Gln Leu Pro
Tyr Gln Pro Ile
Tyr Gln Pro Leu
Vignatic acid B
ibha#22
A 4-O-(1H-indol-3-ylcarbonyl)ascaroside that is icas#22 in which the pro-R hydrogen beta to the carboxy group is replaced by a hydroxy group. It is a metabolite of the nematode Caenorhabditis elegans.
ibho#22
An omega-hydroxy fatty acid ascaroside that is bhos#22 in which the hydroxy group at position 4 of the ascarylopyranose moiety has been has been converted to the corresponding 1H-indole-3-carboxylate ester. It is a metabolite of the nematode Caenorhabditis elegans.
WYE-125132(WYE-132)
WYE-132 (WYE-125132) is a highly potent, ATP-competitive, and specific mTOR kinase inhibitor (IC50: 0.19±0.07 nM; >5,000-fold selective versus PI3Ks). WYE-132 (WYE-125132) inhibits mTORC1 and mTORC2. WYE-132 (WYE-125132) is a highly potent, ATP-competitive, and specific mTOR kinase inhibitor (IC50: 0.19±0.07 nM; >5,000-fold selective versus PI3Ks). WYE-132 (WYE-125132) inhibits mTORC1 and mTORC2.
1-palmitoyl-sn-glycero-3-phospho-l-serine sodium salt
Bomedemstat
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
(3R)-13-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]-3-hydroxytridecanoic acid
(3R,12R)-12-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]-3-hydroxytridecanoic acid
(1R,2S,13S,16S,25S,27S)-1,2,24,24-tetramethyl-22-(2-methylprop-1-enyl)-18,21,23,26-tetraoxa-4-azaoctacyclo[14.13.0.02,13.03,11.05,10.017,19.017,27.020,25]nonacosa-3(11),5,7,9-tetraen-16-ol
[(3R,4S)-1,1-Difluoro-3-(hexadecanoylamino)-4-hydroxy-4-phenylbutyl]phosphonic acid
N-[[(4R,5S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(4S,5S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(4S,5R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(4S,5S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(4R,5R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(4R,5S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(4S,5R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(4R,5R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
(3S)-1-[2-[2,2,2-tris(4-methoxyphenyl)ethoxy]ethyl]-3-piperidinecarboxylic acid
2-amino-3-[hydroxy-[2-hydroxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]phosphoryl]oxypropanoic acid
2-[2,3-Di(trimethylsilyloxy)butoxy]-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
PE(20:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PC(17:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
KRAS inhibitor-10
KRAS inhibitor-10 (compound 11) selectively and effectively inhibit RAS proteins, and particularly KRAS proteins. KRAS inhibitor-10 is an orally active anti-cancer agent and can be used for cancer research, such as pancreatic cancer, breast cancer, multiple myeloma, leukemia and lung cancer. KRAS inhibitor-10 is a?tetrahydroisoquinoline compound (compound 11) extracted from patent WO2021005165 A1[1].
KT185
KT185 is an orally-bioavailable, brain-penetrant and selective ABHD6 inhibitor, with an IC50 0.21 nM in Neuro2A cells[1].